ÂÜÀòÂÒÂ×

Giorgio Ghignoni MD has a diverse work experience in the healthcare industry. Giorgio currently holds the position of Corporate Vice President Scientific Affairs and Innovation Lead at DiaSorin, a global leader in the In Vitro Diagnostic field. Prior to this, they worked at Angelini Pharma as the Corporate Executive Pricing-Market Access and Public Affairs, where they led global product/portfolio pricing, reimbursement, access, and outcomes strategies.

Before that, Ghignoni worked at Bristol-Myers Squibb as the Corporate Executive Director Market Access and Market Access Director, where they were responsible for strategic leadership and operational oversight of market access strategies. Giorgio played a crucial role in shaping product values, supporting local market execution, determining access and pricing strategies, and managing the customer interface.

Ghignoni's work experience also includes positions at Pfizer, where they served as the Executive Director Market Access and Pricing and the Executive Medical Director. Giorgio led various departments including Public Affairs, Regulatory Affairs, Market Access, and Medical Affairs. Giorgio was also appointed as the President of Bioindustria and the Pfizer Italy Foundation for Science and Culture.

Furthermore, Ghignoni has worked at MENARINI Group as the Director Medical, where they managed projects for clinical trials and established the company's International Medical Department.

Overall, Ghignoni's work experience demonstrates their expertise in strategic leadership, market access, pricing, and public affairs in the healthcare industry.

Giorgio Ghignoni MD completed their education as follows: Giorgio received their Doctor of Medicine (M.D.) degree from Sapienza Università di Roma in the years 1985 to 1992. Giorgio then pursued a post-graduate specialization in Respiratory Medicine at the same institution from 1992 to 1995. Continuing their education, Giorgio attended INSEAD in 2006 for Organizational Leadership studies. Giorgio later participated in the General Management Programme/CEDEP at INSEAD in 2011 to 2012. Lastly, they attended Harvard Business School for Finance for Senior Executives in 2008.